[{"id":1,"uid":"NPDI-dCfz1g","name":"Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450","napdiIdentifier":"PMID:11470492","overallSummary":"Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.<br /><br /><br />","pubmedId":11470492,"embaseId":null,"croIdentifier":"T1","croInformation":"Laboratory of Drug Metabolism, Graduate School of Pharmaceutical Sciences, Hokkaido University","dateStart":null,"dateEnd":null,"internalComment":"This is a study reported in the literature. Data was entered by RB (did not enter information about metabolic activation of procarcinogens) and reviewed by JS (entries not complete - please add positive control data and negative data - No significant inhibition of CYP1A1, CYP1A2, CYP2A6, CYP2C9, CYP2E1, or CYP3A4 by (-)-epicatechin or (-)-epigallocatechin was observed at concentrations up to 100 µM in cell membrane fractions with the expression of the respective CYP enzyme together with P450 reductase [one negative entry, CYP1A1 non-inhibition by (-)-epicatechin, has been added by JS as an example]).","status":"published","compoundId":null,"naturalProductUid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","naturalProductSampleId":null,"studySourceTypeId":1,"naturalProduct":{"uid":"NP-028bf4b2-0bc6-458f-b86f-6930ce40efc6","binomial":"Camellia sinensis","name":"Green tea","itis":null,"srs":"e9698137-24da-46f8-a70e-43e27691491f","source_id":"","conceptId":null},"compound":null,"studySourceType":{"id":1,"name":"Published report"},"experiments":[{"id":1,"uid":"NPDI-Cuu5WA","name":null,"overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"N/A","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"The apparent Ki value is presented in the table.<br />Additional study using TA1538 cell membrane fractions of P450 reductase found that (-)-epigallocatechin gallate inhibited this enzyme competitively with an apparent Ki value of 2.5 µM.","internalComment":null,"objectCompoundId":26,"objectMetaboliteCompoundId":1,"precipitantCompoundId":19,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":26,"name":"midazolam","unii":"R60L0SM5BC","inChIKey":"DDLIGBOFAVUZHB-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":708298,"enantiomerOfId":null},"precipitantCompound":{"id":19,"name":"epigallocatechin gallate","unii":"BQM438CTEL","inChIKey":"WMBWREPUVVBILR-WIYYLYMNSA-N","publicDescription":null,"internalComment":null,"conceptId":19058494,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":1,"name":"1'-hydroxymidazolam","unii":null,"inChIKey":"QHSMEGADRFZVNE-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"enzymes":[{"id":13,"name":"CYP3A4","conceptId":4306811,"experiment_enzyme_xref":{"enzymeId":13,"experimentId":1}}],"transporters":[],"quantifiedMetabolites":[]},{"id":127,"uid":"NPDI-p7eJTA","name":null,"overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"N/A","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"The apparent Ki value is presented in the table.<br />Additional study using TA1538 cell membrane fractions of P450 reductase found that (-)-epigallocatechin gallate inhibited this enzyme competitively with an apparent Ki value of 2.5 µM.","internalComment":null,"objectCompoundId":86,"objectMetaboliteCompoundId":87,"precipitantCompoundId":19,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":86,"name":"7-ethoxyresorufin","unii":null,"inChIKey":"CRCWUBLTFGOMDD-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":-7999995,"enantiomerOfId":null},"precipitantCompound":{"id":19,"name":"epigallocatechin gallate","unii":"BQM438CTEL","inChIKey":"WMBWREPUVVBILR-WIYYLYMNSA-N","publicDescription":null,"internalComment":null,"conceptId":19058494,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":87,"name":"resorufin","unii":null,"inChIKey":null,"publicDescription":null,"internalComment":null,"conceptId":-7999853,"enantiomerOfId":null},"enzymes":[{"id":4,"name":"CYP1A2","conceptId":4312402,"experiment_enzyme_xref":{"enzymeId":4,"experimentId":127}}],"transporters":[],"quantifiedMetabolites":[]},{"id":128,"uid":"NPDI-q6-gZQ","name":null,"overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"N/A","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"The apparent Ki value is presented in the table.<br />Additional study using TA1538 cell membrane fractions of P450 reductase found that (-)-epigallocatechin gallate inhibited this enzyme competitively with an apparent Ki value of 2.5 µM.","internalComment":null,"objectCompoundId":11,"objectMetaboliteCompoundId":4,"precipitantCompoundId":19,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":11,"name":"coumarin","unii":null,"inChIKey":"ZYGHJZDHTFUPRJ-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":19008106,"enantiomerOfId":null},"precipitantCompound":{"id":19,"name":"epigallocatechin gallate","unii":"BQM438CTEL","inChIKey":"WMBWREPUVVBILR-WIYYLYMNSA-N","publicDescription":null,"internalComment":null,"conceptId":19058494,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":4,"name":"7-hydroxycoumarin","unii":null,"inChIKey":"ORHBXUUXSCNDEV-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"enzymes":[{"id":5,"name":"CYP2A6","conceptId":4309826,"experiment_enzyme_xref":{"enzymeId":5,"experimentId":128}}],"transporters":[],"quantifiedMetabolites":[]},{"id":129,"uid":"NPDI-vyz23w","name":null,"overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"N/A","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"The apparent Ki value is presented in the table.","internalComment":null,"objectCompoundId":88,"objectMetaboliteCompoundId":11,"precipitantCompoundId":19,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":88,"name":"7-ethoxycoumarin","unii":null,"inChIKey":"LIFAQMGORKPVDH-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"precipitantCompound":{"id":19,"name":"epigallocatechin gallate","unii":"BQM438CTEL","inChIKey":"WMBWREPUVVBILR-WIYYLYMNSA-N","publicDescription":null,"internalComment":null,"conceptId":19058494,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":11,"name":"coumarin","unii":null,"inChIKey":"ZYGHJZDHTFUPRJ-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":19008106,"enantiomerOfId":null},"enzymes":[{"id":32,"name":"CYP1A1","conceptId":4173297,"experiment_enzyme_xref":{"enzymeId":32,"experimentId":129}}],"transporters":[],"quantifiedMetabolites":[]},{"id":130,"uid":"NPDI-38xlLg","name":null,"overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"N/A","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"The apparent Ki value is presented in the table.<br />Additional study using TA1538 cell membrane fractions of P450 reductase found that (-)-epigallocatechin gallate inhibited this enzyme competitively with an apparent Ki value of 2.5 µM.","internalComment":null,"objectCompoundId":14,"objectMetaboliteCompoundId":2,"precipitantCompoundId":19,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":14,"name":"diclofenac","unii":"144O8QL0L1","inChIKey":"DCOPUUMXTXDBNB-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":1124300,"enantiomerOfId":null},"precipitantCompound":{"id":19,"name":"epigallocatechin gallate","unii":"BQM438CTEL","inChIKey":"WMBWREPUVVBILR-WIYYLYMNSA-N","publicDescription":null,"internalComment":null,"conceptId":19058494,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":2,"name":"4'-hydroxydiclofenac","unii":null,"inChIKey":"KGVXVPRLBMWZLG-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"enzymes":[{"id":8,"name":"CYP2C9","conceptId":4309227,"experiment_enzyme_xref":{"enzymeId":8,"experimentId":130}}],"transporters":[],"quantifiedMetabolites":[]},{"id":131,"uid":"NPDI-_5Ix4Q","name":null,"overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"N/A","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"The apparent Ki value is presented in the table. <br />Additional study using TA1538 cell membrane fractions of P450 reductase found that (-)-epigallocatechin gallate inhibited this enzyme competitively with an apparent Ki value of 2.5 µM.","internalComment":null,"objectCompoundId":89,"objectMetaboliteCompoundId":90,"precipitantCompoundId":19,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":89,"name":"4-nitrophenol","unii":null,"inChIKey":null,"publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"precipitantCompound":{"id":19,"name":"epigallocatechin gallate","unii":"BQM438CTEL","inChIKey":"WMBWREPUVVBILR-WIYYLYMNSA-N","publicDescription":null,"internalComment":null,"conceptId":19058494,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":90,"name":"4-nitrocatechol","unii":null,"inChIKey":"XJNPNXSISMKQEX-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"enzymes":[{"id":11,"name":"CYP2E1","conceptId":4173608,"experiment_enzyme_xref":{"enzymeId":11,"experimentId":131}}],"transporters":[],"quantifiedMetabolites":[]},{"id":134,"uid":"NPDI-4i54tA","name":"Percent inhibition of CYP2E1 by epicatechin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"not provided","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"Percent inhibition at 100 µM as estimated from Fig. 3 is presented.","internalComment":null,"objectCompoundId":89,"objectMetaboliteCompoundId":90,"precipitantCompoundId":17,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":89,"name":"4-nitrophenol","unii":null,"inChIKey":null,"publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"precipitantCompound":{"id":17,"name":"epicatechin gallate","unii":"92587OVD8Z","inChIKey":"LSHVYAFMTMFKBA-TZIWHRDSSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":90,"name":"4-nitrocatechol","unii":null,"inChIKey":"XJNPNXSISMKQEX-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"enzymes":[{"id":11,"name":"CYP2E1","conceptId":4173608,"experiment_enzyme_xref":{"enzymeId":11,"experimentId":134}}],"transporters":[],"quantifiedMetabolites":[]},{"id":135,"uid":"NPDI-X_yVFw","name":"Percent inhibition of CYP1A1 by epicatechin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"not provided","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"Percent inhibition at 100 µM as estimated from Fig. 3 is presented.","internalComment":null,"objectCompoundId":88,"objectMetaboliteCompoundId":11,"precipitantCompoundId":17,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":88,"name":"7-ethoxycoumarin","unii":null,"inChIKey":"LIFAQMGORKPVDH-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"precipitantCompound":{"id":17,"name":"epicatechin gallate","unii":"92587OVD8Z","inChIKey":"LSHVYAFMTMFKBA-TZIWHRDSSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":11,"name":"coumarin","unii":null,"inChIKey":"ZYGHJZDHTFUPRJ-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":19008106,"enantiomerOfId":null},"enzymes":[{"id":32,"name":"CYP1A1","conceptId":4173297,"experiment_enzyme_xref":{"enzymeId":32,"experimentId":135}}],"transporters":[],"quantifiedMetabolites":[]},{"id":136,"uid":"NPDI-ArhlIA","name":"Percent inhibition of CYP1A2 by epicatechin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"not provided","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"Percent inhibition at 100 µM as estimated from Fig. 3 is presented.","internalComment":null,"objectCompoundId":86,"objectMetaboliteCompoundId":87,"precipitantCompoundId":17,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":86,"name":"7-ethoxyresorufin","unii":null,"inChIKey":"CRCWUBLTFGOMDD-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":-7999995,"enantiomerOfId":null},"precipitantCompound":{"id":17,"name":"epicatechin gallate","unii":"92587OVD8Z","inChIKey":"LSHVYAFMTMFKBA-TZIWHRDSSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":87,"name":"resorufin","unii":null,"inChIKey":null,"publicDescription":null,"internalComment":null,"conceptId":-7999853,"enantiomerOfId":null},"enzymes":[{"id":4,"name":"CYP1A2","conceptId":4312402,"experiment_enzyme_xref":{"enzymeId":4,"experimentId":136}}],"transporters":[],"quantifiedMetabolites":[]},{"id":137,"uid":"NPDI-CPfQsA","name":"Percent inhibition of CYP2A6 by epicatechin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"not provided","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"Percent inhibition at 100 µM as estimated from Fig. 3 is presented.","internalComment":null,"objectCompoundId":11,"objectMetaboliteCompoundId":4,"precipitantCompoundId":17,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":11,"name":"coumarin","unii":null,"inChIKey":"ZYGHJZDHTFUPRJ-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":19008106,"enantiomerOfId":null},"precipitantCompound":{"id":17,"name":"epicatechin gallate","unii":"92587OVD8Z","inChIKey":"LSHVYAFMTMFKBA-TZIWHRDSSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":4,"name":"7-hydroxycoumarin","unii":null,"inChIKey":"ORHBXUUXSCNDEV-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"enzymes":[{"id":5,"name":"CYP2A6","conceptId":4309826,"experiment_enzyme_xref":{"enzymeId":5,"experimentId":137}}],"transporters":[],"quantifiedMetabolites":[]},{"id":138,"uid":"NPDI-2KGgbg","name":"Percent inhibition of CYP2C9 by epicatechin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"not provided","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"Percent inhibition at 100 µM as estimated from Fig. 3 is presented.","internalComment":null,"objectCompoundId":14,"objectMetaboliteCompoundId":2,"precipitantCompoundId":17,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":14,"name":"diclofenac","unii":"144O8QL0L1","inChIKey":"DCOPUUMXTXDBNB-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":1124300,"enantiomerOfId":null},"precipitantCompound":{"id":17,"name":"epicatechin gallate","unii":"92587OVD8Z","inChIKey":"LSHVYAFMTMFKBA-TZIWHRDSSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":2,"name":"4'-hydroxydiclofenac","unii":null,"inChIKey":"KGVXVPRLBMWZLG-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"enzymes":[{"id":8,"name":"CYP2C9","conceptId":4309227,"experiment_enzyme_xref":{"enzymeId":8,"experimentId":138}}],"transporters":[],"quantifiedMetabolites":[]},{"id":139,"uid":"NPDI-JGDRVA","name":"Percent inhibition of CYP3A4 by epicatechin gallate","overallEffect":1,"isControlData":false,"isIc50Shift":false,"croCutoff":"not provided","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"Percent inhibition at 100 µM as estimated from Fig. 3 is presented.","internalComment":null,"objectCompoundId":26,"objectMetaboliteCompoundId":1,"precipitantCompoundId":17,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":26,"name":"midazolam","unii":"R60L0SM5BC","inChIKey":"DDLIGBOFAVUZHB-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":708298,"enantiomerOfId":null},"precipitantCompound":{"id":17,"name":"epicatechin gallate","unii":"92587OVD8Z","inChIKey":"LSHVYAFMTMFKBA-TZIWHRDSSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"objectMetaboliteCompound":{"id":1,"name":"1'-hydroxymidazolam","unii":null,"inChIKey":"QHSMEGADRFZVNE-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"enzymes":[{"id":13,"name":"CYP3A4","conceptId":4306811,"experiment_enzyme_xref":{"enzymeId":13,"experimentId":139}}],"transporters":[],"quantifiedMetabolites":[]},{"id":142,"uid":"NPDI-pD4STA","name":"Percent inhibition of CYP1A1 by (-)-epicatechin","overallEffect":0,"isControlData":false,"isIc50Shift":false,"croCutoff":"not provided","croIdentifier":null,"comment":null,"experimentalConditionsComment":"Experiments were conducted using TA1538 cell membrane fractions expressing P450 reductase and individual CYP isoforms.","resultsComment":"Percent inhibition at 100 µM as estimated from Fig. 3 is presented.","internalComment":null,"objectCompoundId":88,"objectMetaboliteCompoundId":11,"precipitantCompoundId":66,"cytochromeB5Id":4,"studyId":1,"experimentTypeId":1,"testSystemId":37,"ic50ShiftExperimentId":null,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType":{"id":1,"name":"In Vitro Enzyme Inhibition","isInVitro":true,"isTransporter":false,"isEnzyme":true,"purl":"http://purl.obolibrary.org/obo/DIDEO_00000058"},"objectCompound":{"id":88,"name":"7-ethoxycoumarin","unii":null,"inChIKey":"LIFAQMGORKPVDH-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":null},"precipitantCompound":{"id":66,"name":"(-)-epicatechin","unii":null,"inChIKey":null,"publicDescription":null,"internalComment":null,"conceptId":null,"enantiomerOfId":16},"objectMetaboliteCompound":{"id":11,"name":"coumarin","unii":null,"inChIKey":"ZYGHJZDHTFUPRJ-UHFFFAOYSA-N","publicDescription":null,"internalComment":null,"conceptId":19008106,"enantiomerOfId":null},"enzymes":[{"id":32,"name":"CYP1A1","conceptId":4173297,"experiment_enzyme_xref":{"enzymeId":32,"experimentId":142}}],"transporters":[],"quantifiedMetabolites":[]}]}]